Pharma C Investments - Result of AGM
Announcement provided by
Pharma C Investments Plc · PCIL20/12/2022 16:30
20 December 2022
Pharma C Investments PLC
("Pharma C" or the "Company")
Result of Annual General Meeting
Pharma C Investments (AQSE: PCIL), an early-stage investor and venture builder in the medical cannabis industry with a particular focus on companies that provide ancillary products and services to the medicinal cannabis sectors, announces that at the Annual General Meeting of the Company ("AGM") held at 11 a.m. today, resolutions 1, 2 and 3, as set out in the notice of AGM posted to shareholders on 24 November, were passed, and resolutions 4, 5 and 6.1 to 6.4 were rejected.
Following the AGM, Sharon Segal and Toby Shillito are therefore no longer directors of the Company. The Company will appoint at least one other director as soon as is practically possible.
The Director of the Company accepts responsibility for the contents of this announcement.
This announcement contains inside information for the purposes of Article 7 of the EU Regulation 596/2014 as it forms part of the
For further information please visit www.pharmacinvestments.com
For additional information please contact:
Pharma C Investments
Gavin Sathianathan, Investment Strategy Director
gavin@pharmacinvestments.com
Novum Securities (AQSE Corporate Adviser)
Tel: +44 207 399 9400
David Coffman
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.